Finance

Lists
301281:SHE
Shandong Keyuan Pharmaceutical Co Ltd
CN¥47.25
-1.03%
(-0.49) 1D
Sep 30, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301281...
Open
CN¥47.74
High
CN¥48.59
Low
CN¥46.92
Mkt. cap
5.17B
Avg. vol.
2.60M
Volume
1.59M
Dividend
0.11%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 16, 2026
P/E ratio
132.69
52-wk high
CN¥59.24
52-wk low
CN¥25.87
EPS
CN¥0.36
Shares outstanding
108.29M
No. of employees
650
Open
CN¥47.74
High
CN¥48.59
Low
CN¥46.92
Mkt. cap
5.17B
Avg. vol.
2.60M
Volume
1.59M
Dividend
0.11%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 16, 2026
P/E ratio
132.69
52-wk high
CN¥59.24
52-wk low
CN¥25.87
EPS
CN¥0.36
Shares outstanding
108.29M
No. of employees
650
News stories
From web sources and news partners
About Shandong Keyuan Pharmaceutical Co Ltd
CEO-
Employees650
FoundedDec 27, 2004
Headquarters-
SectorPharmaceutical industry
Websitekeyuanpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
74.82M
95.54M
161.30M
170.16M
Cost of goods sold
39.09M
56.86M
68.39M
78.42M
Cost of revenue
39.09M
56.86M
68.39M
78.42M
Research and development expenses
16.13M
6.86M
5.72M
5.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.69M
35.57M
52.40M
47.01M
Operating expense
40.99M
47.71M
60.30M
50.42M
Total operating expenses
80.08M
104.56M
128.70M
128.85M
Operating income
-5.25M
-9.02M
32.61M
41.32M
Other non operating income
4.39M
-4.31M
-335.82K
2.08M
EBT including unusual items
-11.82M
-15.17M
32.69M
39.96M
EBT excluding unusual items
-566.63K
-11.60M
33.02M
43.28M
Income tax expense
-439.44K
-281.98K
2.16M
6.03M
Effective tax rate
3.72%
1.86%
6.60%
15.08%
Other operating expenses
-3.05M
4.13M
-1.44M
1.59M
Net income
-11.21M
-14.92M
30.07M
34.62M
Net profit margin
-14.99%
-15.61%
18.64%
20.34%
Earnings per share
-
-
-
-
Interest and investment income
814.75K
1.69M
805.04K
59.45K
Interest expense
-
-
-59.45K
-186.95K
Net interest expenses
814.75K
1.69M
745.59K
-127.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
5.57M
2.89M
44.52M
55.17M
Gain or loss from assets sale
-
-303.64K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps